ETS was associated with maintaining HRQOL in an exploratory analysis of the phase III ABSOLUTE trial that assessed the treatment efficacy of nanoparticle albumin-bound paclitaxel vs. solvent-based paclitaxel in second-line chemotherapy for advanced gastric cancer [34]. This evidence concerns the gene ALB and gastric cancer.